Thyroid peroxidase antibody positivity is associated with symptomatic distress in patients with Hashimoto's thyroiditis

Brain, Behavior, and Immunity

Volumn 26, Issue 4, 2012, Pages 559-563

  Müssig, Karsten ^a,b   Künle, Andreas ^a   Säuberlich, Anna Laura ^a   Weinert, Claudia ^a   Ethofer, Thomas ^c   Saur, Ralf ^c   Klein, Reinhild ^a   Häring, Hans Ulrich ^a   Klingberg, Stefan ^c   Gallwitz, Baptist ^a   Leyhe, Thomas ^c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Florence Nightingale Hospital   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Chronic autoimmune thyroiditis; Hashimoto's thyroiditis; Health perception; Physical and mental well being; SCL 90 R; Symptom Checklist 90 Revised

Indexed keywords

LIOTHYRONINE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; DEPRESSION; DISEASE SEVERITY; ENDOCRINE FUNCTION TEST; FEMALE; GLOBAL SEVERITY INDEX; HASHIMOTO DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; OBSESSIVE COMPULSIVE DISORDER; OUTCOME ASSESSMENT; POSITIVE SYMPTOM DISTRESS INDEX; POSITIVE SYMPTOM TOTAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; RATING SCALE; SCORING SYSTEM; SOCIAL PSYCHOLOGY; SOMATIZATION; SYMPTOM CHECKLIST 90; THYROID FUNCTION;

ADULT; AUTOANTIBODIES; DEPRESSION; FEMALE; HASHIMOTO DISEASE; HUMANS; IODIDE PEROXIDASE; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; SEVERITY OF ILLNESS INDEX; SOMATOFORM DISORDERS;

EID: 84859421771     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2012.01.006     Document Type: Article

References (18)

1. Bauer M., Whybrow P.C. Thyroid hormone, neural tissue and mood modulation. World J. Biol. Psychiatry 2001, 2:59-69.
2. Bianchi G.P., Zaccheroni V., Solaroli E., Vescini F., Cerutti R., Zoli M., Marchesini G. Health-related quality of life in patients with thyroid disorders. Qual. Life Res. 2004, 13:45-54.
3. Biondi B., Palmieri E.A., Fazio S., Cosco C., Nocera M., Sacca L., Filetti S., Lombardi G., Perticone F. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J. Clin. Endocrinol. Metab. 2000, 85:4701-4705.
4. Blanchin S., Coffin C., Viader F., Ruf J., Carayon P., Potier F., Portier E., Comby E., Allouche S., Ollivier Y., Reznik Y., Ballet J.J. Anti-thyroperoxidase antibodies from patients with Hashimoto's encephalopathy bind to cerebellar astrocytes. J. Neuroimmunol. 2007, 192:13-20.
5. Carta M.G., Hardoy M.C., Carpiniello B., Murru A., Marci A.R., Carbone F., Deiana L., Cadeddu M., Mariotti S. A case control study on psychiatric disorders in Hashimoto disease and Euthyroid Goitre: not only depressive but also anxiety disorders are associated with thyroid autoimmunity. Clin. Pract. Epidemiol. Ment. Health 2005, 1:23.
6. Chong J.Y., Rowland L.P., Utiger R.D. Hashimoto encephalopathy: syndrome or myth?. Arch. Neurol. 2003, 60:164-171.
7. Dayan C.M., Daniels G.H. Chronic autoimmune thyroiditis. N. Engl. J. Med. 1996, 335:99-107.
8. Engum A., Bjoro T., Mykletun A., Dahl A.A. Thyroid autoimmunity, depression and anxiety; are there any connections? An epidemiological study of a large population. J. Psychosom. Res. 2005, 59:263-268.
9. Ferracci F., Moretto G., Candeago R.M., Cimini N., Conte F., Gentile M., Papa N., Carnevale A. Antithyroid antibodies in the CSF: their role in the pathogenesis of Hashimoto's encephalopathy. Neurology 2003, 60:712-714.
10. Franke, G.H., 2002. Symptom-Checkliste von L.R. Derogatis - Deutsche Version (SCL-90-R). Beltz Test GmbH, Göttingen.
11. Hardoy M.C., Cadeddu M., Serra A., Moro M.F., Mura G., Mellino G., Bhat K.M., Altoe G., Usai P., Piga M., Carta M.G. A pattern of cerebral perfusion anomalies between Major Depressive Disorder and Hashimoto Thyroiditis. BMC Psychiatry 2011, 11:148.
12. Jaeschke R., Guyatt G., Cook D., Harper S., Gerstein H.C. Spectrum of quality of life impairment in hypothyroidism. Qual. Life Res. 1994, 3:323-327.
13. Jaeschke R., Guyatt G., Gerstein H., Patterson C., Molloy W., Cook D., Harper S., Griffith L., Carbotte R. Does treatment with l-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism?. J. Gen. Intern. Med. 1996, 11:744-749.
14. Leyhe T., Müssig K., Weinert C., Laske C., Häring H.U., Saur R., Klingberg S., Gallwitz B. Increased occurrence of weaknesses in attention testing in patients with Hashimoto's thyroiditis compared to patients with other thyroid illnesses. Psychoneuroendocrinology 2008, 33:1432-1436.
15. Müssig K., Leyhe T., Holzmüller S., Klein R., Weinert C., Saur R., Klingberg S., Häring H.U., Gallwitz B. Increased prevalence of antibodies to central nervous system tissue and gangliosides in Hashimoto's thyroiditis compared to other thyroid illnesses. Psychoneuroendocrinology 2009, 34:1252-1256.
16. Ott J., Promberger R., Kober F., Neuhold N., Tea M., Huber J.C., Hermann M. Hashimoto's thyroiditis affects symptom load and quality of life unrelated to hypothyroidism: a prospective case-control study in women undergoing thyroidectomy for benign goiter. Thyroid 2011, 21:161-167.
17. Piga M., Serra A., Deiana L., Loi G.L., Satta L., Di Liberto M., Mariotti S. Brain perfusion abnormalities in patients with euthyroid autoimmune thyroiditis. Eur. J. Nucl. Med. Mol. Imaging 2004, 31:1639-1644.
18. Zettinig G., Asenbaum S., Fueger B.J., Hofmann A., Diemling M., Mittlboeck M., Dudczak R. Increased prevalence of sublinical brain perfusion abnormalities in patients with autoimmune thyroiditis: evidence of Hashimoto's encephalitis?. Clin. Endocrinol. (Oxf) 2003, 59:637-643.